We are live on
!
Find out more
Cerity Partners Portfolio holdings
AUM
$70.8B
1-Year Est. Return
21.68%
This Fund
S&P 500
This Quarter
Est. Return
+5.11%
1 Year Est. Return
+21.68%
3 Year Est. Return
+64.34%
5 Year Est. Return
+67.23%
10 Year Est. Return
–
AUM
$4.21B
AUM Growth
+$1.09B
(+35%)
Cap. Flow
+$955M
Cap. Flow
% of AUM
22.68%
Top 10 Holdings %
Top 10 Hldgs %
34.29%
Holding
765
New
125
Increased
259
Reduced
265
Closed
72
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$110M |
| 2 |
Vanguard FTSE All-World ex-US ETF
VEU
|
+$47.6M |
| 3 |
Apple
AAPL
|
+$45.5M |
| 4 |
Microsoft
MSFT
|
+$37.2M |
| 5 |
Amazon
AMZN
|
+$33.2M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
CMD
Cantel Medical Corporation
CMD
|
+$15.9M |
| 2 |
Caterpillar
CAT
|
+$8.11M |
| 3 |
Golub Capital BDC
GBDC
|
+$7.53M |
| 4 |
Intel
INTC
|
+$6.76M |
| 5 |
iShares Biotechnology ETF
IBB
|
+$6.22M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 17.98% |
| 2 | Industrials | 11.87% |
| 3 | Financials | 10.81% |
| 4 | Healthcare | 9.53% |
| 5 | Consumer Discretionary | 6.14% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
DBD
651
DELISTED
Diebold Nixdorf Incorporated
DBD
| $209K | 0.01% |
14,780
-2,500
| -14% | -$34.4K |
|
652
Cardlytics
CDLX
$22.5M
| $208K | ﹤0.01% |
190
-40
| -17% | -$52.8K |
|
653
lululemon athletica
LULU
$13.6B
| $208K | ﹤0.01% |
679
-7
| -1% | -$2.3K |
|
654
PACCAR
PCAR
$72.3B
| $207K | ﹤0.01% |
+3,339
| New | +$209K |
|
655
Brookfield
BN
$104B
| $206K | ﹤0.01% |
+8,664
| New | +$193K |
|
656
Spotify
SPOT
$104B
| $206K | ﹤0.01% |
+770
| New | +$240K |
|
657
State Street SPDR S&P Regional Banking ETF
KRE
$4.53B
| $205K | ﹤0.01% |
+3,093
| New | +$193K |
|
|
BNY
658
Bank of New York Mellon
BNY
$107B
| $204K | ﹤0.01% |
+4,321
| New | +$190K |
|
659
FirstEnergy
FE
$28.7B
| $204K | ﹤0.01% |
+5,895
| New | +$193K |
|
660
McKesson
MCK
$104B
| $203K | ﹤0.01% |
1,043
-939
| -47% | -$171K |
|
661
Xcel Energy
XEL
$50.5B
| $203K | ﹤0.01% |
3,055
-1,439
| -32% | -$91K |
|
|
AMED
662
DELISTED
Amedisys
AMED
| $202K | ﹤0.01% |
+763
| New | +$215K |
|
663
Diageo
DEO
$49.2B
| $202K | ﹤0.01% |
+1,229
| New | +$201K |
|
664
HEICO Corp
HEI
$50.6B
| $200K | ﹤0.01% |
+1,593
| New | +$205K |
|
665
West Pharmaceutical
WST
$23.8B
| $200K | ﹤0.01% |
+711
| New | +$203K |
|
666
Global Net Lease
GNL
$1.87B
| $196K | ﹤0.01% |
10,870
-1,644
| -13% | -$29.1K |
|
667
UroGen Pharma
URGN
$2B
| $196K | ﹤0.01% |
+10,041
| New | +$213K |
|
668
ProShares Short S&P500
SH
$913M
| $188K | ﹤0.01% |
2,803
| – | – |
|
|
HFRO
669
Highland Opportunities and Income Fund
HFRO
$405M
| $186K | ﹤0.01% |
+16,805
| New | +$177K |
|
|
BPMP
670
DELISTED
BP Midstream Partners LP Common Units representing Limited Partner Interests
BPMP
| $177K | ﹤0.01% |
14,000
+2,000
| +17% | +$24.5K |
|
671
Stagwell
STGW
$1.96B
| $173K | ﹤0.01% |
55,500
| – | – |
|
672
America Movil
AMX
$77.5B
| $157K | ﹤0.01% |
11,551
+311
| +3% | +$4.28K |
|
673
Cerus
CERS
$581M
| $150K | ﹤0.01% |
+25,000
| New | +$170K |
|
|
KLDO
674
DELISTED
Kaleido Biosciences, Inc. Common Stock
KLDO
| $150K | ﹤0.01% |
+18,500
| New | +$202K |
|
|
PTVE
675
DELISTED
Pactiv Evergreen Inc. Common stock
PTVE
| $137K | ﹤0.01% |
10,000
| – | – |
|
Similar funds
Cerity Partners's Q1 2021 Portfolio in Review
As of Q1 2021, Cerity Partners held 765 positions worth $4.21B, up 35% from $3.12B the previous quarter. Its ten largest holdings account for 34% of the portfolio.
Cerity Partners deployed $955M of net new capital in Q1 2021, opening 125 new positions and adding to 259 existing holdings. Its largest new stake was Allogene Therapeutics: 401,602 shares worth $14.2M.
By sector, the portfolio is most concentrated in Technology at 18% of assets, down from 19% a quarter earlier, followed by Industrials and Financials.
On the sell side, the largest reduction was Caterpillar, an estimated $8.11M trimmed.
- Cerity Partners's largest Q1 2021 buy was Allogene Therapeutics: 401,602 shares worth $14.2M.
- Cerity Partners added most to State Street SPDR S&P 500 ETF Trust in Q1 2021, an estimated $110M increase.
- Cerity Partners's biggest Q1 2021 reduction was Caterpillar, cutting an estimated $8.11M.
- Cerity Partners fully exited Cantel Medical Corporation in Q1 2021, selling an estimated $15.9M.
- Cerity Partners's ten largest holdings make up 34% of its $4.21B portfolio in Q1 2021.
- Cerity Partners opened 125 new positions and closed 72 in Q1 2021.
- Cerity Partners's portfolio value rose 35% quarter-over-quarter to $4.21B.
Based on Cerity Partners's 13F filing for Q1 2021, filed 12 May 2021.